Barbara Jacquelyn Sahakian receives funding from the Leverhulme Trust and the Lundbeck Foundation. Her research work is conducted within the NIHR Cambridge Biomedical Research Centre (BRC) Mental ...
The first-line pharmacological treatment for major depressive disorder (MDD) is antidepressant drugs known as selective serotonin reuptake inhibitors (SSRIs). However, a significant proportion of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback